KTYCF.US Kits Eyecare Ltd
- Market cap
- USD 454M
- P/E
- 148.4x
- P/B
- 8.70x
- ROE
- 7.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is KTYCF.US undervalued?
Graham numberThe Graham number of Kits Eyecare Ltd cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Kits Eyecare Ltd fundamental analysis
No fundamental analysis for Kits Eyecare Ltd yet.
Kits Eyecare Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Kits Eyecare Ltd
Kits Eyecare Ltd. operates a digital eyecare platform in the United States and Canada. It offers progressive, polarized, and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands. The company operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. Kits Eyecare Ltd. was founded in 2002 and is headquartered in Vancouver, Canada.
Full company profileKits Eyecare Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Kits Eyecare Ltd annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 36.9M | 75.2M | 82.4M | 91.6M | 121M | 159M | 202M | 240M |
| Gross Profit | 10.8M | 21.4M | 20.9M | 29.2M | 40.8M | 53.6M | 71.2M | 92.2M |
| Operating Income | 2.02M | 122K | -17.0M | -4.35M | -1.43M | 5.43M | 8.26M | 7.36M |
| EBITDA | 3.27M | 1.40M | -14.7M | -721K | 1.86M | 8.31M | 10.6M | 9.63M |
| Net Income | 53.0K | -6.58M | -14.6M | -4.55M | -2.22M | 3.12M | 3.11M | 5.48M |
| EPS | 0.01 | -0.21 | -0.47 | -0.15 | -0.07 | 0.09 | 0.09 | 0.16 |
| Balance Sheet | ||||||||
| Total Assets | 53.4M | 54.7M | 90.9M | 93.9M | 87.6M | 103M | 113M | 114M |
| Total Liabilities | 47.2M | 55.2M | 36.2M | 40.2M | 36.2M | 45.1M | 50.6M | 39.7M |
| Shareholders' Equity | 6.21M | -573K | 54.8M | 53.7M | 51.4M | 57.9M | 62.3M | 74.5M |
| Cash & Short-term Investments | 3.40M | 2.31M | 20.5M | 18.8M | 16.0M | 19.3M | 33.6M | 30.6M |
| Total Debt | 23.9M | 22.3M | 22.9M | 19.4M | 15.4M | 12.6M | 15.8M | 4.94M |
| Cash Flow | ||||||||
| Operating Cash Flow | 4.15M | 4.18M | -19.5M | 4.68M | 2.41M | 13.0M | 11.5M | 10.1M |
| Capital Expenditure | 993K | 225K | 3.63M | 258K | 563K | 3.15M | 136K | 3.72M |
| Free Cash Flow | 3.15M | 3.96M | -23.1M | 4.42M | 1.84M | 9.88M | 11.3M | 6.37M |
| Ratios | ||||||||
| ROE | 0.9% | - | -26.7% | -8.5% | -4.3% | 5.4% | 5.0% | 7.4% |
| ROA | 0.1% | -12.0% | -16.1% | -4.8% | -2.5% | 3.0% | 2.8% | 4.8% |
| Net Profit Margin | 0.1% | -8.8% | -17.7% | -5.0% | -1.8% | 2.0% | 1.5% | 2.3% |
| Debt to Equity | 3.85x | - | 0.42x | 0.36x | 0.30x | 0.22x | 0.25x | 0.07x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Kits Eyecare Ltd dividends
Kits Eyecare Ltd has not paid dividends in the last 7 fiscal years.
Who owns Kits Eyecare Ltd
- Insiders 58.64%
- Institutions 18.21%
- Public & others 23.16%
- Shares outstanding 34.0M
- Free float 14.6M
Kits Eyecare Ltd company profile
- Company name
- Kits Eyecare Ltd
- Ticker
- KTYCF.US
- Exchange
- USA Stocks
- Sector
- Consumer Cyclical
- Industry
- Specialty Retail
- Employees
- 176
- Fiscal year end
- December
- Address
- 510 Seymour Street, Vancouver, BC, Canada, V6B 3J5
- Phone
- 833 487 5487
- Website
- kits.com
About Kits Eyecare Ltd
Kits Eyecare Ltd. operates a digital eyecare platform in the United States and Canada. It offers progressive, polarized, and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands. The company operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. Kits Eyecare Ltd. was founded in 2002 and is headquartered in Vancouver, Canada.
Kits Eyecare Ltd management
7- Mr. Roger V. HardyCo-Founder, CEO & Chairman of the Board · born 1969
- Mr. Tai SilveyPresident
- Mr. Arshil AbdullaCTO & Director · born 1972
- Mr. Ibrahim KamarChief Financial Officer
- Ms. Olivia EvansDirector of Corporate Development & Investor Relations
- Ms. Angela MacInnisChief Marketing Officer
- Allen ZhuController